QT
ENTA icon

Quantbot Technologies’s Enanta Pharmaceuticals ENTA Stock Holding History

Quantbot Technologies’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-400
Closed -$6.98K – 1575
2024
Q1 		$6.98K Sell
400
-4,600
-92% -$60.9K ﹤0.01% 1471
2023
Q4 		$47K Sell
5,000
-2,200
-31% -$20.5K ﹤0.01% 1345
2023
Q3 		$80.4K Buy
7,200
+6,900
+2,300% +$111K 0.01% 1143
2023
Q2 		$6.42K Buy
+300
New +$8.84K ﹤0.01% 1481
2022
Q4 		– Sell
-39
Closed -$2K – 1782
2022
Q3 		$2K Sell
39
-2,258
-98% -$132K ﹤0.01% 1512
2022
Q2 		$108K Buy
2,297
+2,280
+13,412% +$124K 0.01% 1124
2022
Q1 		$1K Sell
17
-5,100
-100% -$332K ﹤0.01% 1579
2021
Q4 		$382K Buy
+5,117
New +$402K 0.03% 597
2021
Q1 		– Sell
-103
Closed -$4K – 1504
2020
Q4 		$4K Buy
+103
New +$4.53K ﹤0.01% 1173
2020
Q1 		– Sell
-3,015
Closed -$186K – 1033
2019
Q4 		$186K Buy
3,015
+2,590
+609% +$161K 0.02% 684
2019
Q3 		$25K Sell
425
-332
-44% -$24.7K ﹤0.01% 1084
2019
Q2 		$63K Buy
+757
New +$68.1K 0.01% 851
2018
Q4 		– Sell
-1,170
Closed -$99K – 1116
2018
Q3 		$99K Buy
+1,170
New +$117K 0.01% 877
2018
Q2 		– Sell
-7,256
Closed -$587K – 1276
2018
Q1 		$587K Buy
+7,256
New +$558K 0.05% 439
2017
Q4 		– Sell
-2,110
Closed -$98K – 1269
2017
Q3 		$98K Buy
+2,110
New +$84.8K 0.01% 844

Other funds holding ENTA

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quantbot Technologies's ENTA Position: Q2 2024 in Review

Quantbot Technologies sold out of Enanta Pharmaceuticals (ENTA) in Q2 2024, closing a stake of 400 shares — an estimated $6.98K sold.

Quantbot Technologies first reported a position in ENTA in Q3 2017 and held it in 15 quarters. The position peaked at $587K in Q1 2018. 100 funds tracked by Wall St. Rank hold ENTA as of Q2 2024.

  • Quantbot Technologies reported no remaining Enanta Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Quantbot Technologies sold 400 Enanta Pharmaceuticals shares in Q2 2024, an estimated $6.98K.
  • Quantbot Technologies first reported a position in Enanta Pharmaceuticals in Q3 2017 and held it in 15 quarters.
  • Quantbot Technologies's Enanta Pharmaceuticals position peaked at $587K in Q1 2018.
  • 100 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2024.

Based on Quantbot Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.